Concepedia

DNA-Based versus RNA-Based Detection of MET Exon 14 Skipping Events in Lung Cancer

Kurtis D. Davies, Aprille Lomboy, Carolyn A. Lawrence, Michael Yourshaw, Gregary T. Bocsi, D. Ross Camidge, Dara L. Aisner

Journal of Thoracic Oncology · 2019 · 150 citations · 12 references

DOIFull text

Open access

Concepts

References

12

Activation of MET via Diverse Exon 14 Splicing Alterations Occurs in Multiple Tumor Types and Confers Clinical Sensitivity to MET Inhibitors

Garrett M. Frampton, Siraj M. Ali, Mark R. Rosenzweig et al. · Cancer Discovery · 2015 · 796 citations · Full text

, , +16

<i>MET</i> Exon 14 Mutations in Non–Small-Cell Lung Cancer Are Associated With Advanced Age and Stage-Dependent <i>MET</i> Genomic Amplification and c-Met Overexpression

Mark M. Awad, Geoffrey R. Oxnard, David M. Jackman et al. · Journal of Clinical Oncology · 2016 · 688 citations · Full text

, , +17

Response to MET Inhibitors in Patients with Stage IV Lung Adenocarcinomas Harboring <i>MET</i> Mutations Causing Exon 14 Skipping

Paul K. Paik, Alexander Drilon, Pang‐Dian Fan et al. · Cancer Discovery · 2015 · 571 citations · Full text

, , +15

Somatic Mutations Lead to an Oncogenic Deletion of Met in Lung Cancer

Monica Kong-Beltran, Somasekar Seshagiri, Jiping Zha et al. · Cancer Research · 2006 · 483 citations

, , +17

<i>MET</i> Amplification and Exon 14 Splice Site Mutation Define Unique Molecular Subgroups of Non–Small Cell Lung Carcinoma with Poor Prognosis

Joanna H. Tong, Sai F. Yeung, Anthony W.H. Chan et al. · Clinical Cancer Research · 2016 · 447 citations · Full text

, , +13